Maximus, Inc. (NYSE:MMS) Shares Purchased by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. increased its holdings in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 45.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 25,615 shares of the health services provider's stock after purchasing an additional 7,980 shares during the period. Robeco Institutional Asset Management B.V.'s holdings in Maximus were worth $1,912,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in the stock. Nordea Investment Management AB purchased a new stake in shares of Maximus in the fourth quarter worth about $4,618,000. Fort Washington Investment Advisors Inc. OH lifted its position in Maximus by 39.1% during the 4th quarter. Fort Washington Investment Advisors Inc. OH now owns 296,476 shares of the health services provider's stock worth $22,132,000 after acquiring an additional 83,390 shares in the last quarter. Versor Investments LP boosted its holdings in Maximus by 213.5% in the 3rd quarter. Versor Investments LP now owns 8,500 shares of the health services provider's stock worth $792,000 after acquiring an additional 5,789 shares during the period. Charles Schwab Investment Management Inc. grew its position in Maximus by 12.4% in the third quarter. Charles Schwab Investment Management Inc. now owns 929,066 shares of the health services provider's stock valued at $86,552,000 after acquiring an additional 102,350 shares in the last quarter. Finally, Citigroup Inc. raised its stake in shares of Maximus by 143.3% during the third quarter. Citigroup Inc. now owns 59,448 shares of the health services provider's stock valued at $5,538,000 after purchasing an additional 35,012 shares during the period. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Maximus

In other Maximus news, CEO Bruce Caswell acquired 3,500 shares of the firm's stock in a transaction on Tuesday, December 17th. The stock was purchased at an average price of $70.64 per share, with a total value of $247,240.00. Following the completion of the acquisition, the chief executive officer now directly owns 275,929 shares in the company, valued at $19,491,624.56. This trade represents a 1.28 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Michelle F. Link sold 2,208 shares of the business's stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $73.83, for a total transaction of $163,016.64. Following the sale, the insider now owns 6,567 shares of the company's stock, valued at approximately $484,841.61. The trade was a 25.16 % decrease in their position. The disclosure for this sale can be found here. Insiders bought a total of 7,063 shares of company stock valued at $502,017 over the last three months. 1.60% of the stock is owned by insiders.

Maximus Stock Down 0.2 %

Shares of MMS traded down $0.14 during trading on Friday, reaching $69.86. The company's stock had a trading volume of 1,378,914 shares, compared to its average volume of 729,773. The company has a market cap of $3.99 billion, a price-to-earnings ratio of 13.97 and a beta of 0.72. The company has a quick ratio of 1.49, a current ratio of 1.49 and a debt-to-equity ratio of 0.59. The company has a fifty day moving average of $74.73 and a two-hundred day moving average of $83.38. Maximus, Inc. has a twelve month low of $68.30 and a twelve month high of $93.97.

Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.78% and a return on equity of 20.95%. On average, sell-side analysts predict that Maximus, Inc. will post 5.95 EPS for the current fiscal year.

Maximus Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 28th. Investors of record on Saturday, February 15th will be paid a $0.30 dividend. The ex-dividend date is Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a yield of 1.72%. Maximus's dividend payout ratio (DPR) is 24.00%.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on MMS shares. StockNews.com raised shares of Maximus from a "hold" rating to a "buy" rating in a report on Thursday. Raymond James upgraded Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 target price for the company in a research note on Thursday, January 2nd.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.